<DOC>
	<DOCNO>NCT00745576</DOCNO>
	<brief_summary>The purpose study evaluate effect multiple dos verapamil plasma concentration single dose SAM-531 healthy young adult subject assess safety tolerability co-administration SAM-531 verapamil .</brief_summary>
	<brief_title>Study Evaluating The Potential Interaction Between Verapamil Immediate Release And SAM-531 When Co-Administered</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Verapamil</mesh_term>
	<criteria>Inclusion criterion : 1 . Body mass index range 18 30 kg/m2 body weight great 50 kg . 2 . Healthy determine investigator basis medical history , physical examination finding , clinical laboratory test result , vital sign measurement , digital 12lead ECG reading . Exclusion criterion : 1 . Presence history disorder may prevent successful completion study . 2 . Any significant cardiovascular , hepatic , renal , respiratory , gastrointestinal ( GI ) , endocrine , immunologic , dermatologic , hematologic , neurologic , psychiatric disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>